Evidence map›Paper›PMID 27792146›Full record

ArticleMolecules (Basel, Switzerland)2016

Piceatannol Exerts Anti-Obesity Effects in C57BL/6 Mice through Modulating Adipogenic Proteins and Gut Microbiota.

Yen-Chen Tung, Yu-Hsuan Lin, Hong-Jhang Chen, Shen-Chieh Chou, An-Chin Cheng, Nagabhushanam Kalyanam, Chi-Tang Ho, Min-Hsiung Pan

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 91 citations in OpenAlex.

  1. Trial
  2. Article
  3. Nutrients · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Piceatannol induces regulatory T cells and modulates the inflammatory response and adipogenesis.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Dietary Polyphenol, Gut Microbiota, and Health Benefits.Antioxidants (Basel, Switzerland) · 2022
    Review
  16. The Anti-Obesity Potential ofDiabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Yen-Chen TungInstitute of Food Sciences and Technology, National Taiwan University, Taipei 10617, Taiwan. emjine@gmail.com.
Yu-Hsuan LinInstitute of Food Sciences and Technology, National Taiwan University, Taipei 10617, Taiwan. gloomy-trf@hotmail.com.
Hong-Jhang ChenInstitute of Food Sciences and Technology, National Taiwan University, Taipei 10617, Taiwan. fsthjchen@ntu.edu.tw.
Shen-Chieh ChouDepartment of Biological Science & Technology, China Medical University, Taichung 40402, Taiwan. shenchieh.chou@gmail.com.
An-Chin ChengDepartment of Tourism, Food and Beverage Management, Chang Jung Christian University, Tainan 71101, Taiwan. anniecheng@mail.cjcu.edu.tw.
Nagabhushanam KalyanamSabinsa Corporation, East Windsor, NJ 08520, USA. kalyanam@sabinsa.com.
Chi-Tang HoDepartment of Food Science, Rutgers University, New Brunswick, NJ 08901, USA. ho@aesop.rutgers.edu.
Min-Hsiung PanInstitute of Food Sciences and Technology, National Taiwan University, Taipei 10617, Taiwan. mhpan@ntu.edu.tw.
National Taiwan University · TWAsia University · TWChang Jung Christian University · TWChina Medical University · TWRutgers, The State University of New Jersey · USSabin Vaccine Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a global health concern. Piceatannol (Pic), an analog of resveratrol (Res), has many reported biological activities. In this study, we investigated the anti-obesity effect of Pic in a high-fat diet (HFD)-induced obese animal model. The results showed that Pic significantly reduced mouse body weight in a dose-dependent manner without affecting food intake. Serum total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL) levels, and blood glucose (GLU) were significantly lowered in Pic-treated groups. Pic significantly decreased the weight of liver, spleen, perigonadal and retroperitoneal fat compared with the HFD group. Pic significantly reduced the adipocyte cell size of perigonadal fat and decreased the weight of liver. Pic-treated mice showed higher phosphorylated adenosine 5'-monophosphate-activated protein kinase (pAMPK) and phosphorylated acetyl-CoA carboxylase (pACC) protein levels and decreased protein levels of CCAAT/enhancer-binding protein C/EBPα, peroxisome proliferator-activated receptor PPARγ and fatty acid synthase (FAS), resulting in decreased lipid accumulation in adipocytes and the liver. Pic altered the composition of the gut microbiota by increasing Firmicutes and

Indexed as

AdipogenesisAnimalsAnti-Obesity AgentsBody WeightCholesterolDiet, High-FatDisease Models, AnimalDose-Response Relationship, DrugEatingGastrointestinal MicrobiomeGene Expression RegulationLipoproteins, HDLLipoproteins, LDLMiceMice, Inbred C57BLObesity3,3',4,5'-tetrahydroxystilbeneAnti-Obesity AgentsCholesterolLipoproteins, HDLLipoproteins, LDLStilbenesAMPKC57BL/6gut microbiotahigh-fat dietobesitypiceatannol

Identifiers

PMID27792146
PMCPMC6273354
OpenAlexW2532393588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.